Financhill
Back

OptimizeRx Stock Predictions

OptimizeRx Stock Forecast

  • Is OptimizeRx Stock Undervalued?
    The current OptimizeRx [OPRX] share price is $4.42. The Score for OPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • OPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will OptimizeRx Stock Go Up Next Year?

Data Unavailable

OptimizeRx Stock Rating

Data Unavailable

OptimizeRx Stock Price History

Is OPRX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Technology
Sector:
Health Care
Type:
stock
Website:
optimizerx.com

52-Week Data

52-Week High:
16.65
52-Week Low:
3.78

Prediction Charts

Market Cap:
81.42M
Price in USD:
4.42
Volume:
544.39K
Beta:
0.84

Technical Analysis

SMA50:
6.43
SMA100:
7.83
SMA200:
10.05
52-Wk Change:
-55.89%

Stock Predictions

  • Is OptimizeRx stock public?
    Yes, OptimizeRx is a publicly traded company.
  • What is the OptimizeRx stock quote today?
    The OptimizeRx stock price is 4.42 USD today.
  • How to buy OptimizeRx stock online?
    You can buy OptimizeRx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 5.20 5.15 5.26 5.13
Nov-4 5.16 5.21 5.40 5.04
Nov-5 5.20 5.11 5.27 5.05
Nov-6 5.49 6.11 6.42 5.31
Nov-7 6.20 6.27 6.64 5.97
Nov-8 6.34 6.28 6.85 6.13
Nov-11 6.32 6.06 6.83 5.90
Nov-12 6.06 5.84 6.06 5.69
Nov-13 5.86 6.17 6.36 5.80
Nov-14 4.75 4.06 4.78 3.95
Nov-15 4.27 3.83 4.28 3.78
Nov-18 3.85 4.20 4.29 3.82
Nov-19 4.18 4.08 4.34 4.03
Nov-20 4.07 4.42 4.53 4.05

OptimizeRx Earnings

Data Unavailable

OptimizeRx Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.07 per share.

* OptimizeRx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.